Compare SUVEN LIFE with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES NOVARTIS SUVEN LIFESCIENCES/
NOVARTIS
 
P/E (TTM) x 20.9 524.2 4.0% View Chart
P/BV x 4.2 29.4 14.4% View Chart
Dividend Yield % 0.5 1.5 33.1%  

Financials

 SUVEN LIFESCIENCES   NOVARTIS
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
NOVARTIS
Mar-19
SUVEN LIFESCIENCES/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs338980 34.5%   
Low Rs169600 28.2%   
Sales per share (Unadj.) Rs52.1198.7 26.2%  
Earnings per share (Unadj.) Rs6.821.0 32.6%  
Cash flow per share (Unadj.) Rs8.622.3 38.5%  
Dividends per share (Unadj.) Rs1.5010.00 15.0%  
Dividend yield (eoy) %0.61.3 46.7%  
Book value per share (Unadj.) Rs65.3307.5 21.2%  
Shares outstanding (eoy) m127.2824.69 515.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.94.0 122.3%   
Avg P/E ratio x37.137.7 98.5%  
P/CF ratio (eoy) x29.635.5 83.3%  
Price / Book Value ratio x3.92.6 151.1%  
Dividend payout %22.047.7 46.0%   
Avg Mkt Cap Rs m32,27219,508 165.4%   
No. of employees `0001.10.6 186.2%   
Total wages/salary Rs m6611,171 56.5%   
Avg. sales/employee Rs Th6,132.28,445.4 72.6%   
Avg. wages/employee Rs Th611.12,015.7 30.3%   
Avg. net profit/employee Rs Th803.5891.0 90.2%   
INCOME DATA
Net Sales Rs m6,6354,907 135.2%  
Other income Rs m242783 31.0%   
Total revenues Rs m6,8775,689 120.9%   
Gross profit Rs m1,604123 1,306.4%  
Depreciation Rs m22132 696.2%   
Interest Rs m3816 237.1%   
Profit before tax Rs m1,587858 185.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718340 211.2%   
Profit after tax Rs m869518 167.9%  
Gross profit margin %24.22.5 966.1%  
Effective tax rate %45.239.6 114.1%   
Net profit margin %13.110.6 124.2%  
BALANCE SHEET DATA
Current assets Rs m6,2328,055 77.4%   
Current liabilities Rs m1,4901,850 80.5%   
Net working cap to sales %71.5126.4 56.5%  
Current ratio x4.24.4 96.1%  
Inventory Days Days8645 192.0%  
Debtors Days Days8334 243.6%  
Net fixed assets Rs m4,043150 2,699.2%   
Share capital Rs m127123 103.2%   
"Free" reserves Rs m8,1837,469 109.6%   
Net worth Rs m8,3107,592 109.5%   
Long term debt Rs m180-   
Total assets Rs m10,3899,824 105.7%  
Interest coverage x43.154.9 78.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 127.9%   
Return on assets %8.75.4 160.8%  
Return on equity %10.56.8 153.4%  
Return on capital %19.511.5 169.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62258 9,760.0%   
Fx outflow Rs m1,7991,326 135.7%   
Net fx Rs m3,822-1,269 -301.3%   
CASH FLOW
From Operations Rs m356-1,943 -18.3%  
From Investments Rs m-2792,742 -10.2%  
From Financial Activity Rs m-225-298 75.5%  
Net Cashflow Rs m-148501 -29.6%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 0.0 1.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 21.5 169.8%  
Shareholders   37,287 41,647 89.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare SUVEN LIFESCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Nov 18, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS